Novel PP2A-Activating Compounds in Neuroblastoma.

In animals bearing SK-N-BE(2) tumors, ATUX-8385 treatment led to a significant decrease in tumor volumes ( Figure 5 C) as well as relative tumor growth ( Figure 5 D), while ATUX-3364 trended toward a decrease but did not reach statistical significance ( Figure 5 C,D).

also in 111,027 other papers